vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and FIRST COMMONWEALTH FINANCIAL CORP (FCF). Click either name above to swap in a different company.
COLLEGIUM PHARMACEUTICAL, INC is the larger business by last-quarter revenue ($205.4M vs $133.7M, roughly 1.5× FIRST COMMONWEALTH FINANCIAL CORP). FIRST COMMONWEALTH FINANCIAL CORP runs the higher net margin — 28.1% vs 8.3%, a 19.8% gap on every dollar of revenue. On growth, FIRST COMMONWEALTH FINANCIAL CORP posted the faster year-over-year revenue change (13.0% vs 12.9%). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs 5.5%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
First Commonwealth Financial Corp is a Pennsylvania-based regional financial services holding company. It offers consumer and commercial banking products, loans, wealth management, and insurance services for individuals, small and mid-sized enterprises across central and western Pennsylvania and Ohio.
COLL vs FCF — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $133.7M |
| Net Profit | $17.0M | $37.5M |
| Gross Margin | 62.5% | — |
| Operating Margin | 29.6% | — |
| Net Margin | 8.3% | 28.1% |
| Revenue YoY | 12.9% | 13.0% |
| Net Profit YoY | 35.3% | 14.8% |
| EPS (diluted) | $0.48 | $0.37 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $133.7M | ||
| Q4 25 | $205.4M | $137.9M | ||
| Q3 25 | $209.4M | $136.0M | ||
| Q2 25 | $188.0M | $131.0M | ||
| Q1 25 | $177.8M | $118.0M | ||
| Q4 24 | $181.9M | $120.4M | ||
| Q3 24 | $159.3M | $121.2M | ||
| Q2 24 | $145.3M | $120.2M |
| Q1 26 | — | $37.5M | ||
| Q4 25 | $17.0M | $44.9M | ||
| Q3 25 | $31.5M | $41.3M | ||
| Q2 25 | $12.0M | $33.4M | ||
| Q1 25 | $2.4M | $32.7M | ||
| Q4 24 | $12.5M | $35.8M | ||
| Q3 24 | $9.3M | $32.1M | ||
| Q2 24 | $19.6M | $37.1M |
| Q1 26 | — | — | ||
| Q4 25 | 62.5% | — | ||
| Q3 25 | 61.7% | — | ||
| Q2 25 | 57.7% | — | ||
| Q1 25 | 54.8% | — | ||
| Q4 24 | 54.0% | — | ||
| Q3 24 | 60.8% | — | ||
| Q2 24 | 62.5% | — |
| Q1 26 | — | — | ||
| Q4 25 | 29.6% | 40.9% | ||
| Q3 25 | 29.7% | 38.1% | ||
| Q2 25 | 18.7% | 32.1% | ||
| Q1 25 | 12.2% | 34.8% | ||
| Q4 24 | 20.9% | 37.1% | ||
| Q3 24 | 21.9% | 33.4% | ||
| Q2 24 | 32.7% | 38.7% |
| Q1 26 | — | 28.1% | ||
| Q4 25 | 8.3% | 32.5% | ||
| Q3 25 | 15.0% | 30.4% | ||
| Q2 25 | 6.4% | 25.5% | ||
| Q1 25 | 1.4% | 27.7% | ||
| Q4 24 | 6.9% | 29.8% | ||
| Q3 24 | 5.9% | 26.5% | ||
| Q2 24 | 13.5% | 30.9% |
| Q1 26 | — | $0.37 | ||
| Q4 25 | $0.48 | $0.44 | ||
| Q3 25 | $0.84 | $0.39 | ||
| Q2 25 | $0.34 | $0.32 | ||
| Q1 25 | $0.07 | $0.32 | ||
| Q4 24 | $0.36 | $0.35 | ||
| Q3 24 | $0.27 | $0.31 | ||
| Q2 24 | $0.52 | $0.36 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | — |
| Total DebtLower is stronger | — | $154.9M |
| Stockholders' EquityBook value | $301.7M | $1.6B |
| Total Assets | $1.7B | $12.3B |
| Debt / EquityLower = less leverage | — | 0.10× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $386.7M | — | ||
| Q3 25 | $285.9M | — | ||
| Q2 25 | $222.2M | — | ||
| Q1 25 | $197.8M | — | ||
| Q4 24 | $162.8M | — | ||
| Q3 24 | $120.0M | — | ||
| Q2 24 | $271.6M | — |
| Q1 26 | — | $154.9M | ||
| Q4 25 | — | $261.7M | ||
| Q3 25 | — | $262.1M | ||
| Q2 25 | — | $262.4M | ||
| Q1 25 | — | $262.7M | ||
| Q4 24 | — | $263.0M | ||
| Q3 24 | — | $136.3M | ||
| Q2 24 | — | $136.6M |
| Q1 26 | — | $1.6B | ||
| Q4 25 | $301.7M | $1.6B | ||
| Q3 25 | $274.8M | $1.5B | ||
| Q2 25 | $232.2M | $1.5B | ||
| Q1 25 | $234.4M | $1.4B | ||
| Q4 24 | $228.8M | $1.4B | ||
| Q3 24 | $234.3M | $1.4B | ||
| Q2 24 | $216.6M | $1.4B |
| Q1 26 | — | $12.3B | ||
| Q4 25 | $1.7B | $12.3B | ||
| Q3 25 | $1.6B | $12.3B | ||
| Q2 25 | $1.6B | $12.2B | ||
| Q1 25 | $1.6B | $11.8B | ||
| Q4 24 | $1.7B | $11.6B | ||
| Q3 24 | $1.6B | $12.0B | ||
| Q2 24 | $1.1B | $11.6B |
| Q1 26 | — | 0.10× | ||
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.17× | ||
| Q2 25 | — | 0.17× | ||
| Q1 25 | — | 0.18× | ||
| Q4 24 | — | 0.19× | ||
| Q3 24 | — | 0.10× | ||
| Q2 24 | — | 0.10× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | — |
| Free Cash FlowOCF − Capex | $122.4M | — |
| FCF MarginFCF / Revenue | 59.6% | — |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | 7.25× | — |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $123.0M | $187.5M | ||
| Q3 25 | $78.4M | $49.5M | ||
| Q2 25 | $72.4M | $30.4M | ||
| Q1 25 | $55.4M | $55.9M | ||
| Q4 24 | $84.6M | $129.5M | ||
| Q3 24 | $-9.0M | $53.6M | ||
| Q2 24 | $67.4M | $22.7M |
| Q1 26 | — | — | ||
| Q4 25 | $122.4M | $171.5M | ||
| Q3 25 | $78.3M | — | ||
| Q2 25 | $72.4M | — | ||
| Q1 25 | $54.6M | — | ||
| Q4 24 | $84.1M | $113.9M | ||
| Q3 24 | $-9.2M | — | ||
| Q2 24 | $67.1M | — |
| Q1 26 | — | — | ||
| Q4 25 | 59.6% | 124.3% | ||
| Q3 25 | 37.4% | — | ||
| Q2 25 | 38.5% | — | ||
| Q1 25 | 30.7% | — | ||
| Q4 24 | 46.2% | 94.6% | ||
| Q3 24 | -5.8% | — | ||
| Q2 24 | 46.2% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | 11.7% | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 0.3% | 12.9% | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.2% | — |
| Q1 26 | — | — | ||
| Q4 25 | 7.25× | 4.18× | ||
| Q3 25 | 2.49× | 1.20× | ||
| Q2 25 | 6.05× | 0.91× | ||
| Q1 25 | 22.92× | 1.71× | ||
| Q4 24 | 6.75× | 3.61× | ||
| Q3 24 | -0.96× | 1.67× | ||
| Q2 24 | 3.44× | 0.61× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
